A5075222043- Tuberculosis Research and Epidemiology
- Infection Control and Ventilation
- Mycobacterium research and diagnosis
- COVID-19 and healthcare impacts
- Long-Term Effects of COVID-19
- COVID-19 Clinical Research Studies
- Dental Research and COVID-19
- Nanoparticles: synthesis and applications
- Innovative Microfluidic and Catalytic Techniques Innovation
Southern University of Science and Technology
2020-2024
Shenzhen Third People’s Hospital
2024
University of Hong Kong
2021
Abstract The commonly-used drug susceptibility testing (DST) relies on bacterial culture and faces shortcomings such as long turnaround time clone/subclone selection. We developed a targeted deep amplification sequencing (DAS) method directly applied to clinical specimens. In this DAS panel, we examined 941 drug-resistant mutations associated with 20 anti-tuberculosis drugs an initial amount of 4 pg DNA reduced from days two days. A prospective study was conducted using 115 specimens mainly...
Background: In December 2019, a cluster of acute respiratory illness caused by SARS-CoV-2, now known as Coronavirus Disease 2019 (COVID-19), occurred in Wuhan, Hubei Province, China. We describe and compare the clinical characteristics inpatients intensive care unit (ICU) non-ICU cases with COVID-19, features heart injury were described emphatically. Methods: recruited patients who diagnosed COVID-19 from Shenzhen Third People's Hospital China divided into two groups, ICU Non-ICU...